Marijuana and the Pediatric Population

Pediatrics. 2020 Aug;146(2):e20192629. doi: 10.1542/peds.2019-2629. Epub 2020 Jul 13.

Abstract

Cannabinoids, the psychoactive compounds in marijuana, are one of the most commonly used substances in the United States. In this review, we summarize the impact of marijuana on child and adolescent health and discuss the implications of marijuana use for pediatric practice. We review the changing epidemiology of cannabis use and provide an update on medical use, routes of administration, synthetic marijuana and other novel products, the effect of cannabis on the developing brain, other health and social consequences of use, and issues related to marijuana legalization.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adolescent Behavior / drug effects
  • Animals
  • Brain / drug effects
  • Brain / embryology
  • Brain / growth & development
  • Cannabidiol / pharmacology
  • Cannabidiol / therapeutic use
  • Cannabinoids / adverse effects
  • Cannabinoids / chemical synthesis
  • Cannabinoids / pharmacology
  • Cannabis* / adverse effects
  • Cannabis* / chemistry
  • Cannabis* / poisoning
  • Child
  • Child Behavior / drug effects
  • Drug Interactions
  • Endocannabinoids / physiology
  • Female
  • Fetus / drug effects
  • Humans
  • Illicit Drugs / adverse effects
  • Male
  • Marijuana Abuse / epidemiology
  • Marijuana Abuse / therapy
  • Marijuana Use* / adverse effects
  • Marijuana Use* / epidemiology
  • Marijuana Use* / legislation & jurisprudence
  • Marijuana Use* / psychology
  • Mass Media
  • Medical Marijuana / adverse effects
  • Medical Marijuana / therapeutic use
  • Milk, Human / chemistry
  • Neurocognitive Disorders / chemically induced
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Receptors, Cannabinoid / drug effects
  • Receptors, Cannabinoid / physiology
  • Tobacco Use / epidemiology

Substances

  • Cannabinoids
  • Endocannabinoids
  • Illicit Drugs
  • Medical Marijuana
  • Receptors, Cannabinoid
  • Cannabidiol